 
            IndraLab
Statements
PRPF8 activates intein-mediated protein splicing. 1 / 1
                        
    
      
      
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
      
    
      
      
        |
        
      
      
        
      
        
      
        
          
          1
          
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
      
    
  
                      
                    
                                      reach
                                
                                  
                                
                                
          
          
                                  "The recent discovery of a small molecule inhibitor of the Prp8 intein that selectively inhibits splicing without targeting proteases and inhibits the growth of intein-containing C. gattii and C. neoformans is a particularly exciting breakthrough that suggests intein inhibitors may have therapeutic benefits (Li et al., 2021)."